John C. Malone Professor of Molecular, Cellular, and Developmental Biology
Professor of Chemistry, of Pharmacology, and of Management
Executive Director, Yale Center for Molecular Discovery
Yale School of Medicine
New Haven, Connecticut
For excellence in drug discovery and development spanning from molecule to patient and his work on pharmacological modulation of protein turnover. Combining groundbreaking science with strong entrepreneurship, he has spearheaded new and revolutionary therapeutic approaches including the development of novel proteasome inhibitors and proteolysis targeting chimera (PROTAC) technology, enabling the drugging of cancer targets previously considered undruggable.
The AACR-Irving Weinstein Foundation Distinguished Lectureship was established in 2004 to acknowledge an individual whose outstanding scientific innovation and thought leadership has inspired creative thinking and new directions in cancer research. The recipient of this award is selected annually by the AACR president. Crews was chosen by David A. Tuveson, MD, PhD, FAACR, AACR president for the 2021-2022 term.
To learn more, please visit the press release.